Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-020872
Filing Date
2022-08-04
Accepted
2022-08-04 07:57:11
Documents
84
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20220630.htm   iXBRL 10-Q 1662518
2 EX-31.1 lnth10q-063022ex311.htm EX-31.1 11781
3 EX-31.2 lnth10q-063022ex312.htm EX-31.2 11667
4 EX-32.1 lnth10q-063022ex321.htm EX-32.1 9857
  Complete submission text file 0001628280-22-020872.txt   7761942

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20220630.xsd EX-101.SCH 47586
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20220630_cal.xml EX-101.CAL 98147
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20220630_def.xml EX-101.DEF 181276
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20220630_lab.xml EX-101.LAB 593960
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20220630_pre.xml EX-101.PRE 372095
78 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20220630_htm.xml XML 1512870
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 221134760
SIC: 2835 In Vitro & In Vivo Diagnostic Substances